Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl M J Kirkpatrick

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Current Pharmaceutical Biotechnology|May 11, 2011
Pharmacokinetic concepts revisited--basic and appliedKashyap Patel, Carl M J Kirkpatrick
Age and Ageing|March 22, 2021
New Horizons in the impact of frailty on pharmacokinetics: latest developmentsSarah N Hilmer, Carl M J Kirkpatrick
British Journal of Clinical Pharmacology|July 23, 2021
Science fiction has become reality: Best practice for future viral pandemicsDaniel F B Wright, Carl M J Kirkpatrick
British Journal of Clinical Pharmacology|November 13, 2007
Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic studyStefanie Hennig, Ross Norris, Carl M J Kirkpatrick
Intensive Care Medicine|March 8, 2007
Population pharmacokinetics and pharmacodynamics of cefpirome in critically ill patients against Gram-negative bacteriaJuliana F Roos, Jeffrey Lipman, Carl M J Kirkpatrick
Journal of Pharmacokinetics and Pharmacodynamics|March 28, 2009
Informative study designs to identify true parameter-covariate relationshipsPhey Yen Han, Carl M J Kirkpatrick, Bruce Green
British Journal of Clinical Pharmacology|June 25, 2010
Current dosing of low-molecular-weight heparins does not reflect licensed product labels: an international surveyMichael A Barras, Carl M J Kirkpatrick, Bruce Green
Journal of Psychiatry & Neuroscience : JPN|May 12, 2023
Consistent terminology for medication-related problems in pharmacogenomic casesThomas M Polasek, Sam Mostafa, Carl M J Kirkpatrick
The Journal of Antimicrobial Chemotherapy|December 2, 2010
Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patientsJason A Roberts, Carl M J Kirkpatrick, Jeffrey Lipman
Therapeutic Advances in Drug Safety|December 20, 2019
Precision dosing to avoid adverse drug reactionsThomas M Polasek, Carl M J Kirkpatrick, Amin Rostami-Hodjegan
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Current Pharmaceutical Biotechnology|May 11, 2011
Pharmacokinetic concepts revisited--basic and appliedKashyap Patel, Carl M J Kirkpatrick
Age and Ageing|March 22, 2021
New Horizons in the impact of frailty on pharmacokinetics: latest developmentsSarah N Hilmer, Carl M J Kirkpatrick
British Journal of Clinical Pharmacology|July 23, 2021
Science fiction has become reality: Best practice for future viral pandemicsDaniel F B Wright, Carl M J Kirkpatrick
British Journal of Clinical Pharmacology|November 13, 2007
Target concentration intervention is needed for tobramycin dosing in paediatric patients with cystic fibrosis--a population pharmacokinetic studyStefanie Hennig, Ross Norris, Carl M J Kirkpatrick
Intensive Care Medicine|March 8, 2007
Population pharmacokinetics and pharmacodynamics of cefpirome in critically ill patients against Gram-negative bacteriaJuliana F Roos, Jeffrey Lipman, Carl M J Kirkpatrick
Journal of Pharmacokinetics and Pharmacodynamics|March 28, 2009
Informative study designs to identify true parameter-covariate relationshipsPhey Yen Han, Carl M J Kirkpatrick, Bruce Green
British Journal of Clinical Pharmacology|June 25, 2010
Current dosing of low-molecular-weight heparins does not reflect licensed product labels: an international surveyMichael A Barras, Carl M J Kirkpatrick, Bruce Green
Journal of Psychiatry & Neuroscience : JPN|May 12, 2023
Consistent terminology for medication-related problems in pharmacogenomic casesThomas M Polasek, Sam Mostafa, Carl M J Kirkpatrick
The Journal of Antimicrobial Chemotherapy|December 2, 2010
Monte Carlo simulations: maximizing antibiotic pharmacokinetic data to optimize clinical practice for critically ill patientsJason A Roberts, Carl M J Kirkpatrick, Jeffrey Lipman
Therapeutic Advances in Drug Safety|December 20, 2019
Precision dosing to avoid adverse drug reactionsThomas M Polasek, Carl M J Kirkpatrick, Amin Rostami-Hodjegan
Pageof 11